Skip to main content
Pandemics, Patents, and Price Controls
Researchers at the UW Medicine Retrovirology Research Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trial on February 12, 2021 in Seattle, Washington
(Photo by Karen Ducey/Getty Images)

Pandemics, Patents, and Price Controls

Adam Mossoff

Summary

The COVID-19 pandemic has shown the world what decades of patent protection has made possible in the biopharmaceutical sector of the U.S. innovation economy. Nonetheless, price controls now threaten to stifle this innovation. If the government twists its own laws and arbitrarily imposes price controls on patented vaccines and drugs created by pharmaceutical innovators, innovation will not occur. Statist price controls kill innovation, destroy markets, and stymie or degrade economic development. We should prevent politicians and activists from exploiting the COVID-19 crisis to undermine both patents and biopharmaceutical advancement—harming people today and preventing an effective response to the next pandemic.

Read the full report in Heritage Foundation

Related Articles

2021 Annual Report

Hudson Institute

2021 began with most of the United States still shuttered by the COVID-19 pandemic— and ended with most of the world on edge due to the massing of Rus...

Continue Reading

Now Is the Time to Expose Chinese Corruption

Nate Sibley

When Xi Jinping in March banned senior Communist Party officials and their families from owning significant overseas assets, many took it as a sign th...

Continue Reading

Big Tech's Sticky Fingers Are Still at Work in Washington

Adam Mossoff

Big Tech is strongly criticized in Congress these days, but it still has sway in Washington when it lobbies Congress to weaken the U.S. patent system....

Continue Reading